Corporate Update
Zoll Receives FDA Clearance to Market E-Series Defibrillators
Zoll Receives FDA Clearance to Market E-Series Defibrillators
![]()
By eHealth Network - 06 January 2010
ZOLL Medical Corporation has received 510(k) clearance from the U.S. FDA.
Integrating CO-Oximetry into the E Series Monitor/Defibrillator adds a critical, life-saving tool for medics to use in emergency situations.
CO measurement is a breakthrough that helps rescuers noninvasively and immediately diagnose, monitor, and treat patients.
Now with integrated Masimo
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
